Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Bristol-Myers Squibb Co    BMY   US1101221083

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/23/2015 03/24/2015 03/25/2015 03/26/2015 03/27/2015 Date
67.58(c) 65.69(c) 64.7(c) 65(c) 65.26(c) Last
4 523 257 10 532 632 7 000 981 5 799 704 4 955 870 Volume
-0.27% -2.80% -1.51% +0.46% +0.40% Change
More quotes
Financials ($)
Sales 2015 15 209 M
EBIT 2015 3 155 M
Net income 2015 2 792 M
Finance 2015 1 781 M
Yield 2015 2,27%
Sales 2016 16 903 M
EBIT 2016 4 316 M
Net income 2016 3 788 M
Finance 2016 2 723 M
Yield 2016 2,38%
PER 2015 37,96
PER 2016 27,71
EV / Sales 2015 7,03x
EV / Sales 2016 6,27x
Capitalization 108 767 M
More Financials
Company
Bristol-Myers Squibb Co. is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products.Its pharmaceutical products include chemically-synthesized drugs or small molecules and an increasing portion of products produced from... 
Sector
Pharmaceuticals
Calendar
04/01Ex-dividend day
More about the company
Surperformance© ratings of Bristol-Myers Squibb Co
Trading Rating : Investor Rating :
More Ratings
Latest news on BRISTOL-MYERS SQUIBB CO
03/27 BRISTOL MYERS SQUIBB : to Announce Results for First Quarter 2015 on April 28
03/27 BRISTOL MYERS SQUIBB : Acquires Exclusive License from Novo Nordisk
03/27 U.S. biotech stocks may fall further as short interest rises
03/26 ALBANY MOLECULAR RESEARCH : Bristol-Myers Squibb Assigned Patent
03/25 BRISTOL MYERS SQUIBB : Recent Findings from Bristol-Myers Squibb Provides New In..
03/25 BRISTOL MYERS SQUIBB : Researchers at Bristol-Myers Squibb Release New Data on L..
03/25 BRISTOL MYERS SQUIBB : New General Science Study Findings Have Been Reported by ..
03/25 BRISTOL MYERS SQUIBB : Trademark Application for "PREGESTIMIL" Filed by Bristol-..
More news
Sector news : Pharmaceuticals - NEC
03/27 HOSPIRA : first biosimilar could be its first to gain FDA approval
03/27 VALEANT PHARMACEUTICALS INTL : S&P Dow Jones Indices Announces Changes to the S&..
03/27DJGilead Sciences CEO's Pay Rose 23% Last Year
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/27 SEEKING ALPHA'S BIOTECH WEEKLY : Gilead Cardiac Flap, Ohr Sinks, MEI Selloff, An..
03/27 European approval of Bristol-Myers' Opdivo remains elusive
03/24 TODAY'S MARKET : 5 Stocks Moving On News
03/24 Merck's Keytruda tops Bristol-Myers' Yervoy in melanoma trial
03/24 Bristol-Myers Squibb's Opdivo Breezes Through FDA; Multiple Catalysts To Come


Comments 
Advertisement
Chart BRISTOL-MYERS SQUIBB CO
Duration : Period :
Bristol-Myers Squibb Co Technical Analysis Chart | BMY | US1101221083 | 4-Traders
Full-screen chart
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF